Effect of tyrosine kinase inhibitors on the cytotoxic activity against HIV-1 infection

• S. Rodríguez-Mora,
• G. Bautista,
• E. Mateos,
• V. García,
• J.L. Steegmann,
• J. Ambrosioni,
• Nuria Climent,
• F. Cervantes,
• J.M. Miró,
• M. Plana,
• J. Alcamí,
• M. Coiras

Affiliations

S. Rodríguez-Mora

AIDS Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain

G. Bautista

Clinical Hematology Service, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain

E. Mateos

AIDS Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain

V. García

Infectious Diseases Service, Hospital Ramón y Cajal, Madrid Spain

J.L. Steegmann

Hematology and Hemotherapy Service, Hospital Universitario de La Princesa, Madrid, Spain

J. Ambrosioni

Infectious Diseases Service, Hospital Clínic, IDIBAPS, Barcelona, Spain

Nuria Climent

Retrovirology and Viral Immunopathology Laboratory, AIDS Research Group, Hospital Clínic, IDIBAPS, Barcelona, Spain

F. Cervantes

Hematology Department, Hospital Clínic, IDIBAPS, Barcelona, Spain

J.M. Miró

Infectious Diseases Service, Hospital Clínic, IDIBAPS, Barcelona, Spain

M. Plana

Retrovirology and Viral Immunopathology Laboratory, AIDS Research Group, Hospital Clínic, IDIBAPS, Barcelona, Spain

J. Alcamí

AIDS Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain

M. Coiras

AIDS Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain